Vaccine effectiveness in preventing laboratory-confirmed influenza in primary care patients in a season of co-circulation of influenza A(H1N1)pdm09, B and drifted A(H3N2), I-MOVE Multicentre Case–Control Study, Europe 2014/15

Low effectiveness of seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2014/15 mid–season results

(2015) R G Pebody et al.   Eurosurveillance

Interim estimates of 2014/15 vaccine effectiveness against influenza A(H3N2) from Canada’s Sentinel Physician Surveillance Network, January 2015

(2015) D M Skowronski et al.   Eurosurveillance

Effectiveness of seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2014/15 end of season results

(2015) Richard Pebody et al.   Eurosurveillance

Trivalent inactivated seasonal influenza vaccine effectiveness for the prevention of laboratory-confirmed influenza in a Scottish population 2000 to 2009

(2015) C R Simpson et al.   Eurosurveillance

The European I-MOVE Multicentre 2013–2014 Case-Control Study. Homogeneous moderate influenza vaccine effectiveness against A(H1N1)pdm09 and heterogenous results by country against A(H3N2)

(2015) Marta Valenciano et al.   VACCINE

Influenza vaccine effectiveness estimates in Europe in a season with three influenza type/subtypes circulating: the I-MOVE multicentre case–control study, influenza season 2012/13

(2014) E Kissling et al.   Eurosurveillance

Stratified Estimates of Influenza Vaccine Effectiveness by Prior Vaccination: Caution Required

(2013) S. G. Sullivan et al.   CLINICAL INFECTIOUS DISEASES

Influenza Vaccine Effectiveness in the 2011–2012 Season: Protection Against Each Circulating Virus and the Effect of Prior Vaccination on Estimates

(2013) Suzanne E. Ohmit et al.   CLINICAL INFECTIOUS DISEASES

Association between Patient Age and Influenza A Subtype during Influenza Outbreaks

(2010) Bonita E. Lee et al.   INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY